Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD). (Q32041277)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD). |
scientific article |
Statements
1 reference
Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD). (English)
1 reference
Rasmussen H
1 reference
Chu KW
1 reference
Campochiaro P
1 reference
Gehlbach PL
1 reference
Haller JA
1 reference
Handa JT
1 reference
Nguyen QD
1 reference
Sung JU
1 reference
1 November 2001
1 reference
1 reference